References
Jurynczyk M, Messina S, Woodhall MR, Raza N, Everett R, Roca-Fernandez A, Tackley G, Hamid S, Sheard A, Reynolds G, Chandratre S, Hemingway C, Jacob A, Vincent A, Leite MI, Waters P, Palace J (2017) Clinical presentation and prognosis in MOG-antibody disease: a UK study. Brain 140:3128–3138
Ogawa R, Nakashima I, Takahashi T, Kaneko K, Akaishi T, Takai Y, Sato DK, Nishiyama S, Misu T, Kuroda H, Aoki M, Fujihara K (2017) MOG antibody-positive, benign, unilateral, cerebral cortical encephalitis with epilepsy. Neurol Neuroimmunol Neuroinflamm 4:e322
Fujimori J, Takai Y, Nakashima I, Sato DK, Takahashi T, Kaneko K, Nishiyama S, Watanabe M, Tanji H, Kobayashi M, Misu T, Aoki M, Fujihara K (2017) Bilateral frontal cortex encephalitis and paraparesis in a patient with anti-MOG antibodies. J Neurol Neurosurg Psychiatry 88:534–536
Nagabushana D, Shah R, Pendharkar H, Agrawal A, Kulkarni GB, Rajendran S, Alladi S, Mahadevan A (2019) MOG antibody seropositive aseptic meningitis: a new clinical phenotype. J Neuroimmunol 333:476960
Yanagida A, Iizuka T, Nagai T, Usui R, Kaneko J, Akutsu T, Hanajima R, Kanazawa N, Nishiyama K (2017) MOG-IgG-positive multifocal myelitis with intrathecal IgG synthesis as a spectrum associated with MOG autoimmunity: two case reports. J Neurol Sci 382:40–43
Titulaer MJ, Höftberger R, Iizuka T, Leypoldt F, McCracken L, Cellucci T, Benson LA, Shu H, Irioka T, Hirano M, Singh G, Cobo Calvo A, Kaida K, Morales PS, Wirtz PW, Yamamoto T, Reindl M, Rosenfeld MR, Graus F, Saiz A, Dalmau J (2014) Overlapping demyelinating syndromes and anti–N-methyl-D-aspartate receptor encephalitis. Ann Neurol 75:411–428
Kaneko K, Sato DK, Misu T, Kurosawa K, Nakashima I, Fujihara K, Aoki M (2014) Anti-N-methyl-D-aspartate receptor encephalitis with multiphasic demyelination. Ann Neurol 76:462–464
Zhou L, ZhangBao J, Li H, Li X, Huang Y, Wang M, Zhao C, Lu J, Lu C, Li Y, Quan C (2017) Cerebral cortical encephalitis followed by recurrent CNS demyelination in a patient with concomitant anti-MOG and anti-NMDA receptor antibodies. Mult Scler Relat Disord 18:90–92
Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M, Dessain SK, Rosenfeld MR, Balice-Gordon R, Lynch DR (2008) Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 7:1091–1098
Acknowledgments
The authors thank Professor Josep Dalmau in Service of Neurology, IDIBAPS Hospital Clínic, University of Barcelona, Casanova (Spain), for examining antibodies against cell-surface antigens and critical comments on this study. We also thank Dr. Keiko Tanaka in Department of Animal Model Development, Brain Research Institute, Niigata University (Japan), for examining anti-NMDAR-antibodies.
Funding
This work was supported in part by the Japan Epilepsy Research Foundation (JERF TENKAN 17002, TI).
Author information
Authors and Affiliations
Contributions
EA and AM equally contributed to drafting and revising the manuscript, data collection, study concept, and interpretation of data. NK and TI contributed to data collection, interpretation of data, and revising the manuscript. All authors give final approval of the version to be published.
Corresponding author
Ethics declarations
Conflict of interest
EA, AM, and NK do not have anything to disclose regarding conflicts of interest or commercial relationships including grants, honoraria, speaker’s lists, significant ownership, or financial support from pharmaceutical or other companies. TI received a grant from The Japan Epilepsy Research Foundation and research support from Astellas Pharma Inc.
Ethical approval
Informed consent was obtained from the patient described in this article.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
ESM 1
(DOCX 42 kb)
Rights and permissions
About this article
Cite this article
Amano, E., Machida, A., Kanazawa, N. et al. Cerebrospinal fluid MOG-antibodies in anti-NMDA receptor encephalitis with leptomeningeal enhancement. Neurol Sci 41, 2635–2638 (2020). https://doi.org/10.1007/s10072-020-04343-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-020-04343-3